Histone deacetylases in skeletal development and bone mass maintenance

Gene. 2011 Mar 15;474(1-2):1-11. doi: 10.1016/j.gene.2010.12.003. Epub 2010 Dec 22.

Abstract

The skeleton is a multifunctional and regenerative organ. Dynamic activities within the bone microenvironment necessitate and instigate rapid and temporal changes in gene expression within the cells (osteoclasts, osteoblasts, and osteocytes) responsible for skeletal maintenance. Regulation of gene expression is controlled, in part, by histone deacetylases (Hdacs), which are intracellular enzymes that directly affect chromatin structure and transcription factor activity. Key roles for several Hdacs in bone development and biology have been elucidated though in vitro and in vivo models. Recent findings suggest that clinical usage of small molecule Hdac inhibitors for conditions like epilepsy, bipolar disorder, cancer, and a multitude of other ailments may have unintended effects on bone cell populations. Here we review the progress that has been made in the last decade in understanding how Hdacs contribute to bone development and maintenance.

Publication types

  • Review

MeSH terms

  • Animals
  • Bone Development / drug effects
  • Bone Development / genetics
  • Bone Development / physiology*
  • Bone and Bones / drug effects
  • Bone and Bones / enzymology*
  • Bone and Bones / physiology
  • Gene Expression Regulation, Developmental / drug effects
  • Histone Deacetylase Inhibitors / classification
  • Histone Deacetylase Inhibitors / pharmacology
  • Histone Deacetylases / genetics
  • Histone Deacetylases / metabolism*
  • Humans
  • Mice
  • Osteoblasts / drug effects
  • Osteoblasts / enzymology
  • Osteoclasts / drug effects
  • Osteoclasts / enzymology
  • Rats
  • Transcription Factors / genetics
  • Transcription Factors / metabolism

Substances

  • Histone Deacetylase Inhibitors
  • Transcription Factors
  • Histone Deacetylases